- EFFICACY OF SACUBITRIL/VALSARTAN INMAINTENANCE HEMODIALYSIS PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTIONFu, Sha; Wang, Xiaohong; Song, Qirong; Chen, Junzhe; Tang, Ying60th ERA Congress, Milan, ITALY, 2023-06-15 To 2023-06-18.
- Evaluation of Sacubitril/Valsartan Initiation in Outpatient Heart Failure PatientsLindsey, Rerick; Colleen, Elston; Jordan, Kester; Courtney, Montepara; Brooke, GenglerJournal of Cardiovascular Pharmacology, 2021, 77(3): 343-348.
- THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH EGFR <30 ML/MIN/1.73M2: FINDINGS FROM THE DAPA-CKD TRIALChertow, G.; Vart, P.; Jongs, N.; Toto, R.; Gorriz, J. L.; Hou, F. F.; Mcmurray, J.; Correa-Rotter, R.; Rossing, P.; Sjostrom, C. D.; Stefansson, B. V.; Langkilde, A. M.; Wheeler, D. C.; Heerspink, H. J. L.
会议论文
EFFICACY AND SAFETY OF SACUBITRIL/VALSARTAN IN PATIENTS WITH STAGE 3B-5 CKD AND HYPERTENSION
17阅读
